Skip to main content
Español

News: FDA Announces Shelf-Life Extension for Narcan (naloxone) Nasal Spray

News & Articles (Drugs.com)

FDA Announces Shelf-Life Extension for Narcan (naloxone) Nasal Spray Medically reviewed by Judith Stewart, BPharm . Last updated on Jan 18, 2024. January 17, 2024 -- Today, FDA is announcing that Emergent BioSolutions is extending the shelf-life of newly manufactured NARCAN ( naloxone hydrochloride...

News: Racial Disparity Seen in Naloxone Administration

News & Articles (Drugs.com)

Meds for Opioid Addiction THURSDAY, June 20, 2024 -- About one-third of community outpatient mental health treatment facilities (MHTFs) offer medications for opioid use disorder (MOUD), according to a... More news resources FDA Medwatch Drug Alerts Daily MedNews News for Health Professionals New Drug...

News: Few Young Adults Could Administer Naloxone to Reverse Fentanyl Overdose

News & Articles (Drugs.com)

...treating opioid addiction, a new study finds.Standard care for... More news resources FDA Medwatch Drug Alerts Daily MedNews News for Health Professionals New Drug Approvals New Drug Applications Drug Shortages Clinical Trial Results Generic Drug Approvals Subscribe to our newsletter Whatever your topic of...

FDA Alert: Opioid Pain Relievers or Medicines to Treat Opioid Use Disorder - FDA Recommends Health Care Professionals Discuss Naloxone with All Patients when Prescribing

Drug Alerts (FDA)

Opioid Pain Relievers or Medicines to Treat Opioid Use Disorder - FDA Recommends Health Care Professionals Discuss Naloxone with All Patients when Prescribing July 23, 2020 Audience: Consumer, Health Professional, Pharmacy ISSUE : FDA is requiring drug manufacturers for all opioid pain relievers...

FDA Approves Rezenopy (naloxone hydrochloride) Nasal Spray for the Emergency Treatment of Opioid Overdose

New Drug Approvals (FDA)

FDA Approves Rezenopy FDA Approves Rezenopy (naloxone hydrochloride) Nasal Spray for the Emergency Treatment of Opioid Overdose April 19, 2024 -- The U.S. Food and Drug Administration has approved Rezenopy (naloxone hydrochloride) nasal spray 10 mg for the emergency treatment of known or suspected...

FDA Alert: FDA Alerts Health Care Professionals of Risks to Patients Exposed to Xylazine in Illicit Drugs

Drug Alerts (FDA)

..., as naloxone may not be able to reverse its effects. FDA is aware of increasing reports of serious side effects from individuals exposed to fentanyl, heroin, and other illicit drugs contaminated with xylazine. Xylazine is FDA-approved for use in animals as a sedative and pain reliever. Xylazine is not...

News: High Out-of-Pocket Costs Keep Some From Lifesaving Opioid Antidote

News & Articles (Drugs.com)

...-pocket cost of naloxone prescriptions could help achieve this goal,” lead researcher Dr. Kao-Ping Chua , an assistant professor at the University of Michigan Medical School and School of Public Health, said in a university news release. However, researchers also found that cost is only one barrier...

News: Biden Administration Calls for Greater Access to Overdose Antidote

News & Articles (Drugs.com)

...to treat the disorder, a new... Supreme Court Rejects Purdue Pharma Opioid Settlement FRIDAY, June 28, 2024 -- The U.S. Supreme Court on Thursday struck down a controversial settlement that drug maker Purdue Pharma had reached with victims of the opioid... More news resources FDA Medwatch Drug Alerts...

FDA Alert: Drug Safety Communication: All Opioid Pain Medicines - FDA Updates Prescribing Information to Provide Additional Guidance for Safe Use

Drug Alerts (FDA)

...allow you to obtain naloxone without a prescription from a community-based program or pharmacy. Check with your state Health Department for more information. In March 2023 , FDA approved an inhaled nasal spray version of naloxone to be sold over-the-counter without a prescription while multiple forms of...

News: Few Receive Meds for Opioid Use Disorder After Nonfatal Overdose

News & Articles (Drugs.com)

...... Patient–Primary Care Provider Language Concordance Tied to Better Outcomes TUESDAY, July 2, 2024 -- Patient-family physician language concordance is associated with a lower risk for adverse outcomes, according to a study published online June 3... More news resources FDA Medwatch Drug Alerts Daily MedNews...